UNSPSC 51431706: Benazepril hydrochloride

This classification denotes an ace inhibitor with the molecular formula C24H28N2O5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier N1SN99T69T, chemically known as 1h-1-benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, monohydrochloride, (s-(r*,r*))- but more generally known as benazepril hydrochloride, which bears US NIH Compound Identifier 5362123.

UNSPSC 51431706 Benazepril hydrochloride is a Commodity code for a specific antihypertensive medication supplied to state and local health systems, emergency services, and pharmacy benefit programs. State and local governments procure this product as part of broader pharmaceutical supply agreements serving emergency medical services, public health agencies, and employee health plans. The code appears in solicitations for Advanced Life Support medications supplied to fire and rescue departments, as well as in multistate cooperative purchasing agreements for generic pharmaceuticals distributed across state and local healthcare facilities. Issuing bodies include municipal purchasing offices (such as city fire departments), state health agencies, and multistate cooperative purchasing alliances. These procurement mechanisms span both direct supply agreements and vendor management through authorized pharmaceutical wholesalers.

Recent activity concentrates in Florida and Minnesota, with emerging state-level interest in Texas. The City of Tampa's Purchasing Department solicited Advanced Life Support Medications (Bid No. 26-P-00188) via IFB with a due date of April 8, 2026 for Tampa Fire Rescue, with an estimated contract value of $40,000 and a one-year term plus optional renewals; the solicitation carried a 5 percent SLBE bid discount. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP for generic multi-source pharmaceuticals and OTC products (S1070000015802) with a proposal deadline of March 26, 2026, requiring vendor pricing through three authorized wholesalers (AmerisourceBergen, Cardinal Health, and Morris & Dickson) with a contract effective date of July 1, 2026. The Texas Health and Human Services Commission posted an RFI (HHS0017013) on March 27, 2026 regarding direct-to-manufacturer prescription programs, signaling upstream state interest in alternative pharmacy supply models. These recent opportunities show the code active across municipal emergency services, state health agency cooperative purchasing, and multistate purchasing collaboratives seeking standardized pharmaceutical supply and pricing arrangements.